openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizie

News

Discover

Novartis — news, coverage & facts — IJR

|NewsJournalsOrganizationNovartis

Novartis · Public domain

Organization

Novartis

Swiss-American multinational pharmaceutical corporation

11 members

Feed News Media Community Map About

11 members1 mentions · 24hcoverage spread: L31/C31/R38

Comments

Ask this entity anything:

Free account · your comment posts right after signup

Sandoz Henlius Expand Biosimilars Alliance to Ten Assets
Sandoz and Shanghai Henlius Biotech announced a strategic collaboration to develop and globally commercialize up to 10 monoclonal antibody and antibody-drug conjugate biosimilars outside China, with Henlius leading development and manufacturing and milestone-based total consideration potentially reaching USD 322 million. The initial deal covers cetuximab, evolocumab and belimumab biosimilars, expanding the partners’ biosimilars pipeline amid a broader push to capture a growing segment of the loss-of-exclusivity market.
6 sources
Photo: forextime.com / Wikimedia Commons (CC BY 2.0)
XY Capital Expands Holdings Across Global Stocks

Facts from Wikidata (CC0). Image via Wikimedia Commons (Public domain).

XY Capital Ltd disclosed new or increased positions across five companies in Q1: Novartis, Yum China, Infosys, MINISO Group Holding, and NIO, with specific share purchases ranging from roughly 8,770 to 444,350 shares and portfolio weights from about 2.7% to 8.8%. Yum China became XY Capital’s largest holding, while MINISO and NIO occupy mid-range positions as the firm expands its diversified equity exposure.

7 sources

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.

Read the full article →

Country: Switzerland
Headquarters: Basel
Inception: 1996
Website: http://www.novartis.com/

Related

Dan Vasellachief executive Joseph Jimenezchief executive Vasant Narasimhanchief executive German-Swiss Chamber of Commercemember of Freiwillige Selbstkontrolle für die Arzneimittelindustriemember of Bundesverband der Pharmazeutischen Industriemember of Verband Forschender Arzneimittelherstellermember of American Chamber of Commerce to the European Unionmember of Spitzenverband Digitale Gesundheitsversorgung e.V.member of Deutsche Krebsgesellschaft (German Cancer Society)member of Vision Zero e.V.member of Bundesverband Gesundheits-IT – bvitg e. V.member of